跳至主要内容
临床试验/NCT07034378
NCT07034378已完成不适用

Comparison of Extended Cryoballoon Ablation, Standard Cryoballoon Ablation, and Radiofrequency Catheter Ablation in Patients With Persistent Atrial Fibrillation: A Multicenter, Randomized Controlled Clinical Trial

Asan Medical Center3 个研究点 分布在 1 个国家目标入组 288 人开始时间: 2021年9月28日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
288
试验地点
3
主要终点
the incidence rates of atrial tachyarrhythmias

研究概览

简要总结

The objective of this study is to test the efficacy hypothesis that extended cryoballoon ablation is superior to either standard cryoballoon ablation or radiofrequency ablation

详细描述

The posterior wall of the left atrium is known to contribute to arrhythmogenicity and has been associated with higher rates of atrial fibrillation (AF) recurrence. In this trial, we aim to evaluate whether extended cryoballoon ablation-comprising pulmonary vein isolation (PVI) plus posterior wall isolation-results in superior rhythm outcomes compared to standard cryoballoon ablation (PVI only) or radiofrequency ablation (PVI only). Patients will be randomly assigned to one of three treatment arms: extended cryoballoon ablation, standard cryoballoon ablation, or radiofrequency ablation. Each patient will receive the assigned treatment accordingly. The primary outcome is the incidence of atrial tachyarrhythmias-including atrial fibrillation, atrial flutter, and atrial tachycardia-lasting more than 30 seconds, occurring after discontinuation of antiarrhythmic drugs and following a 3-month post-procedure blanking period. Outcomes will be compared at 1 year after the procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged between 18-80 years
  • Patients with persistent (≥7 days) AF documented on 12-lead ECG or Holter monitoring.
  • AF refractory/intolerant to class I or III antiarrhythmic drugs
  • Able and willing to provide written informed consent to CB or RF ablation and participation in this investigation

排除标准

  • Age <18 years old or >80 years old
  • Paroxysmal AF lasting <7 days
  • Mitral stenosis or mechanical prosthetic valve
  • Patients with left atrial size ≥ 50 mm (2D echocardiography, Anterior-posterior diameter in parasternal long axis view)
  • Anatomy of pulmonary vein not suitable for standard CB or extended CB, including common ostium or ostium size > 26mm
  • Pregnant woman of childbearing age with a positive pregnancy test before treatment
  • Presence of atrial septal defect or patent foramen ovale closure device
  • Presence of intracardiac thrombus
  • Contraindications to the systemic anticoagulation
  • NYHA functional class IV heart failure
  • Prior catheter or surgical ablation of AF
  • Acute coronary syndrome within 3 months
  • Planned open heart surgery within 3 months
  • Prior open-heart surgery within 3 months
  • End stage renal disease or chronic kidney disease (estimated glomerular filtration rate [MDRD method] < 30mL/min/1.73m²)
  • Life expectancy less than 1 year.

结局指标

主要结局

the incidence rates of atrial tachyarrhythmias

时间窗: 3-month blanking period post-procedure

Incidence of atrial tachyarrhythmias (including atrial fibrillation, flutter, or tachycardia) lasting \>30 seconds after discontinuation of antiarrhythmic therapy, assessed following a 3-month blanking period

次要结局

  • Incidence of peri-procedural complications(Periprocedural)
  • Atrial arrhythmia recurrence during blanking period(during blanking period (3 months))
  • Atrial tachycardia or flutter recurrence(1 year)
  • Atrial fibrillation recurrence(1 year)
  • Rate of first-pass isolation or first-freeze isolation(during procedure)
  • Procedure duration (minutes)(during procedure)
  • Ablation time (minutes)(during procedure)
  • Fluoroscopy time (minutes)(during procedure)
  • LA dwelling time(during procedure)
  • Ablation time (seconds)(during procedure)
  • Quality of life changes at 12 months compared to baseline(1 year)
  • Number of repeat procedures(1 year)
  • AF burden by 2-week patch monitoring(1 year)
  • LA pressure, mmHg (max/min/mean)(during procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gi-Byoung Nam

Professor

Asan Medical Center

研究点 (3)

Loading locations...

相似试验